Profit saw 4% hike in 2024, Prodia unveils strategy for this year
14 Mar 2025 16:07
Prodia's (PRDA) revenue rose by only 1.3%, while profit grew by 4%. What's its strategy for 2025?
Optimizing laboratory services, MTMH now controls 80% of GGI
19 Dec 2024 10:39
PT Murni Sadar Tbk (MTMH), the operator of Murni Teguh Hospitals, has acquired 80% of the shares of PT Global Genetika Indonesia (GGI) for IDR 3.56 billion to enhance its medical laboratory services.
Prodia's net profit corrected 17.5% at the end of September 2024
01 Nov 2024 14:58
PT Prodia Widyahusada Tbk (PRDA), the company that oversees the Prodia laboratory network, is still experiencing a downward trend in net profit until September 2024.
Securing medical device supply chain, Prodia spends IDR 72 billion on 39% of Proline
28 Jun 2024 12:51
PT Prodia Widyahusada Tbk (PRDA) takes an extra measure to secure supply chain of in vitro diagnostic (IVD) test tools by acquiring 39% of its affiliate, PT Prodia Diagnostic Line (Proline).
Hesitating on IKN, Prodia allocates 55% of capex to IT
18 Apr 2024 16:06
PT Prodia Widyahusada Tbk (PRDA) has prepared moderate amount of capital expenditure (capex) in 2024, worth a maximum of IDR 250 billion.
Profit pressured by normalisation, Prodia still set up dividend of IDR 155.6 billion
18 Apr 2024 11:14
PT Prodia Widyahusada Tbk (PRDA), a company managing Prodia laboratory network, has allocated IDR 155.6 billion to be distributed to its shareholders as cash dividend.
After suffering losses, Diagnos to acquire DNA data company Asa Ren
14 Mar 2024 14:02
PT Diagnos Laboratorium Utama Tbk (DGNS) will acquire 97.97% of the shares of Asa Ren Pte. Ltd, an AI-based DNA data company registered in Singapore, with a transaction value estimated at IDR 357.89 billion.
Diagnos Laboratorium reported its first loss since debut
05 Mar 2024 11:35
PT Diagnos Laboratorium Utama Tbk (DGNS), a medical laboratory service provider under PT Bundamedik Tbk (BMHS), booked a loss of IDR 13.65 billion in 2023.